Nanotechnology could help with prostate cancer treatment options
the ONA take:
Novel nanotechnology could help men with prostate cancer make better decisions in treatment options, a study published in PLUS One suggested.
Researchers from Northwestern University led by Vadim Backman, PhD, used an optical technique he pioneered called partical wave spectroscopic (PWS) microscopy. The technology is able to detect cell features as precise as 20 nanometers which would help to distinguish cells that would appear normal with standard microscopy techniques.
The researchers analyzed prostate tissue biopsies from two cohorts of men with prostate cancer. They found a dramatic increase in nano-architectural disorder in progressors as compared to non-progressors.
As the first study to use PWS microscopy to predict cancer prognosis, the authors stated that the technology could be effective in avoiding unnecessary aggressive treatment in men with prostate cancer, which could lead to adverse events.
Novel nanotechnology could help men with prostate cancer make better decisions in treatment options.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|